Neostigmine Methylsulfate (pf recalls
The FDA has published 2 recalls involving Neostigmine Methylsulfate (pf since 2019. The latest was reported on 9 Oct 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 9 Oct 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why neostigmine methylsulfate (pf is recalled
Companies
By year
All neostigmine methylsulfate (pf recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | NEOstigmine Methylsulfate (PF), 3 mg/ (1 mg/mL) Single Dose Syringe recalled | KRS Global Biotechnology | Sterility | Nationwide |
| Drug | CLASS II | NEOstigmine Methylsulfate (PF), 5 mg/ (1 mg/mL) fill recalled | KRS Global Biotechnology | Sterility | Nationwide |
Should you stop taking Neostigmine Methylsulfate (pf?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.